TY - JOUR
T1 - Chromosome 14–encoded Alzheimer's disease
T2 - Genetic and clinicopathological description
AU - Haltia, Matti
AU - Viitanen, Matti
AU - Sulkava, Raimo
AU - Ala‐Hurula, Veli
AU - Poyhonen, Minna
AU - Goldfarb, Lev
AU - Brown, Paul
AU - Levy, Efrat
AU - Houlde, Henry
AU - Crook, Richard
AU - Goate, Alison
AU - Clark, Robert
AU - Korenblat, Kevin
AU - Pandit, Sunil
AU - Keller, Helen Donis
AU - Llius, Lena
AU - Liu, Li
AU - Axelman, Karin
AU - Forsell, Lotta
AU - Winblad, Bengt
AU - Lannfelt, Lars
AU - Hardy, John
PY - 1994/9
Y1 - 1994/9
N2 - A family of Finnish descent with very‐early‐onset Alzheimer's disease has been identified. Genetic analysis of this family eliminated the amyloid precursor protein gene as the pathogenic locus, but strongly implicated a locus on chromosome 14q23.4 between D14S52 and D14S55. The early age at onset of the disease (average, 36 years; range, 35–39 years), the rapid progression, and the early and prominent myoclonus, while they appear to be frequent findings in the chromosome 14–encoded form of Alzheimer's disease, raised the clinical suspicion of prion disease. However, sequencing the prion gene–coding region of 2 affected members of the pedigree failed to show any abnormality. Apart from the presence of modest cortical vacuolar change, the pathological features of our index patient appeared typical of Alzheimer's disease with abundant senile plaques immunoreactive with beta‐amyloid, but not with prion protein antibodies.
AB - A family of Finnish descent with very‐early‐onset Alzheimer's disease has been identified. Genetic analysis of this family eliminated the amyloid precursor protein gene as the pathogenic locus, but strongly implicated a locus on chromosome 14q23.4 between D14S52 and D14S55. The early age at onset of the disease (average, 36 years; range, 35–39 years), the rapid progression, and the early and prominent myoclonus, while they appear to be frequent findings in the chromosome 14–encoded form of Alzheimer's disease, raised the clinical suspicion of prion disease. However, sequencing the prion gene–coding region of 2 affected members of the pedigree failed to show any abnormality. Apart from the presence of modest cortical vacuolar change, the pathological features of our index patient appeared typical of Alzheimer's disease with abundant senile plaques immunoreactive with beta‐amyloid, but not with prion protein antibodies.
UR - http://www.scopus.com/inward/record.url?scp=0028067657&partnerID=8YFLogxK
U2 - 10.1002/ana.410360307
DO - 10.1002/ana.410360307
M3 - Article
C2 - 8080244
AN - SCOPUS:0028067657
SN - 0364-5134
VL - 36
SP - 362
EP - 367
JO - Annals of neurology
JF - Annals of neurology
IS - 3
ER -